Targeting Hypoxia Inducible Factors-1α As a Novel Therapy in Fibrosis
Fibrosis, characterized by increased extracellular matrix (ECM) deposition, and widespread vasculopathy, has the prominent trait of chronic hypoxia. Hypoxia inducible factors-1α (HIF-1α), a key transcriptional factor in response to this chronic hypoxia, is involved in fibrotic disease, such as Syste...
Saved in:
Main Authors: | Anji Xiong (Author), Yi Liu (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2017-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Hypoxia Inducible Factor-1α (HIF-1α): A Biomarker for Detection of Malignant Transformation in Oral Submucous Fibrosis
by: Kanwal Iqbal, et al.
Published: (2024) -
Hypoxia Inducible Factor1α in Correlation with Preeclampsia
by: Hendrik Juarsa, et al.
Published: (2016) -
Hypoxia-Inducible Factor-1α (HIF-1α) as a Biomarker for Changes in Microcirculation in Individuals with Systemic Sclerosis
by: Magdalena Maciejewska, et al.
Published: (2023) -
Targeting Hypoxia-Inducible Factor-1α in Pancreatic Cancer: siRNA Delivery Using Hyaluronic Acid-Displaying Nanoparticles
by: Alice Spadea, et al.
Published: (2024) -
Exploration on the relationship between hypoxia inducible factor-1α and morbidly adherent placenta
by: J.Y. Yan, et al.
Published: (2020)